Financials
Income statement
Fiscal date | May 2024 | Feb 2024 | Nov 2023 | Aug 2023 |
---|---|---|---|---|
Total reported revenue | 29.0B | 18.8B | 21.7B | 19.2B |
Cost of revenue | 12.4B | 6.3B | 8.6B | 7.3B |
Gross profit | 16.6B | 12.5B | 13.1B | 11.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 2.5B | 2.7B | 3.0B | 2.3B |
Non operating interest income | ||||
Income | 211M | 191M | 274M | 169M |
Expense | 136M | -35M | 98M | 17M |
Other income expense | — | — | — | — |
Pretax income | 14.2B | 2.9B | 2.4B | 3.1B |
Tax provision | 3.3B | 802M | 1.1B | 1.1B |
Net income | 10.9B | 2.1B | 1.3B | 2.0B |
Basic EPS | — | — | — | 44.2 |
Diluted EPS | — | — | — | 44.2 |
Basic average shares | — | — | — | 44.3M |
Diluted average shares | — | — | — | 44.3M |
EBITDA | 2.9B | 2.8B | 2.7B | 3.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | -22M | 3M | -40M | -15M |
Preferred stock dividends | 0 | 0 | 0 | 0 |